Ocular Therapeutix, Inc. (OCUL)
6.205
-0.08
(-1.19%)
USD |
NASDAQ |
Nov 13, 16:00
6.20
0.00 (0.00%)
After-Hours: 19:59
Ocular Therapeutix Price : 6.205 for Nov. 13, 2026
Price Chart
Historical Price Data
| Date | Open | High | Low | Close | Volume |
|---|---|---|---|---|---|
| Nov 12, 2026 | 6.51 | 6.66 | 6.27 | 6.28 | 2.337M |
| Nov 11, 2026 | 6.63 | 6.82 | 6.48 | 6.66 | 2.990M |
| Nov 10, 2026 | 6.86 | 6.87 | 6.60 | 6.61 | 2.658M |
| Nov 09, 2026 | 6.25 | 6.87 | 6.05 | 6.85 | 3.556M |
| Nov 06, 2026 | 6.53 | 6.745 | 6.52 | 6.595 | 1.957M |
| Nov 05, 2026 | 7.15 | 7.24 | 6.41 | 6.43 | 3.130M |
| Nov 04, 2026 | 7.09 | 7.165 | 6.83 | 7.14 | 3.361M |
| Nov 03, 2026 | 6.815 | 6.97 | 6.76 | 6.82 | 2.001M |
| Nov 02, 2026 | 6.97 | 7.03 | 6.575 | 6.73 | 1.883M |
| Oct 30, 2026 | 7.27 | 7.38 | 6.92 | 6.97 | 2.630M |
| Oct 29, 2026 | 7.36 | 7.535 | 7.29 | 7.31 | 2.211M |
| Oct 28, 2026 | 6.68 | 7.34 | 6.60 | 7.29 | 2.854M |
| Oct 27, 2026 | 6.48 | 6.75 | 6.42 | 6.72 | 2.215M |
| Oct 26, 2026 | 6.50 | 6.62 | 6.40 | 6.47 | 1.691M |
| Oct 23, 2026 | 6.68 | 6.68 | 6.345 | 6.50 | 1.856M |
| Oct 22, 2026 | 6.42 | 6.665 | 6.395 | 6.61 | 2.145M |
| Oct 21, 2026 | 6.69 | 6.750 | 6.375 | 6.48 | 2.492M |
| Oct 20, 2026 | 6.30 | 6.775 | 6.30 | 6.65 | 2.617M |
| Oct 19, 2026 | 7.13 | 7.18 | 6.00 | 6.29 | 8.358M |
| Oct 16, 2026 | 7.38 | 7.39 | 6.85 | 6.87 | 2.762M |
| Oct 15, 2026 | 7.29 | 7.465 | 7.23 | 7.38 | 3.253M |
| Oct 14, 2026 | 7.14 | 7.30 | 7.07 | 7.20 | 2.209M |
| Oct 13, 2026 | 7.55 | 7.61 | 7.20 | 7.24 | 3.216M |
| Oct 12, 2026 | 7.60 | 7.75 | 7.36 | 7.56 | 3.670M |
| Oct 09, 2026 | 7.49 | 7.68 | 7.38 | 7.54 | 2.630M |
Price Definition
The price of a security measures the cost to purchase 1 share of a security. For a company, price can be multiplied by shares outstanding to find the market capitalization (value of the company).
Price Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Price Benchmarks
| EyePoint, Inc. | 0.3099 |
| ANI Pharmaceuticals, Inc. | 71.47 |
| Eli Lilly & Co. | 1444.57 |
| Corcept Therapeutics, Inc. | 72.96 |
| Veru, Inc. | 2.12 |
Price Related Metrics
| PS Ratio | 27.63 |
| PEG Ratio | -3.156 |
| Price to Book Value | 3.094 |
| Earnings Yield | -23.46% |
| Market Cap | 1.364B |
| PEGY Ratio | -3.156 |